Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
批准号:
10626099
负责人:
Justin Berk
金额:
$19.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-05-31
关键词:
AddressAdherenceBuprenorphineCOVID-19 pandemicCaringCessation of lifeClinicalClinical MedicineClinical TrialsCommunitiesCorrectional InstitutionsCriminal JusticeDataData SetDatabasesDedicationsDevelopmentDisparityDropoutDrug ScreeningEffectivenessEnrollmentEpidemicEthicsEvaluationEventFamiliarityFoundationsFundingFutureGeneral PopulationGoalsGrantHigh PrevalenceImprisonmentIndividualInjectableInstitutionInterventionInterviewJailLifeLinkLiteratureMeasuresMentorsMethodologyMethodsModalityMonitorOverdosePatientsPersonsPharmaceutical PreparationsPilot ProjectsPoliciesPopulationPrisonsPublic HealthPublishingRandomized, Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch PersonnelResourcesRhode IslandRiskSamplingScientistSiteStandardizationStatutes and LawsSurveysSystemTimeTrainingTreatment outcomeUnited States National Institutes of HealthUrineVulnerable PopulationsWorkaddictioncareercohortcommunity settingcostcourteffective therapyeffectiveness clinical trialevidence baseexperiencefollow-uphealth care settingshealth managementhigh riskillicit opioidimplementation barriersimplementation evaluationimplementation facilitatorsimplementation frameworkimplementation outcomesimplementation scienceinterestmarginalized populationmedication for opioid use disordermortalitynovelopioid mortalityopioid overdoseopioid useopioid use disorderpatient orientedpreventprimary outcomeprocess evaluationprogramsracial disparityreincarcerationsecondary outcomeskillssocial stigmatreatment as usualtreatment centertreatment comparisontrial comparinguptake
中文摘要
项目摘要
这项K23申请提出了在矫正治疗中阿片类药物使用障碍(OUD)治疗的新研究。
医疗保健环境和强大的培训计划,以支持Dr. Justin Berk,MD的成功过渡
MPH MBA(PI)独立临床科学家。他在公共卫生、卫生管理和
临床医学为作为专家科学家的进一步发展奠定了坚实的基础。他组建了
一个由国家认可的导师和顾问组成的高度成就和多元化的团队,
在脆弱人群中进行临床试验和其他研究的专门知识,包括定性方法
和实施科学。拟议的研究工作将提供实践经验,有助于博士。
Berk作为临床试验者的职业发展为未来的多中心R 01应用提供了初步数据。的
罗得岛惩教署(RIDOC)是这类试点研究的理想场所。
阿片类药物使用障碍(MOUD)的药物是一种有效的治疗方法,在社区和
被监禁的人。鉴于监狱和监狱中OUD的高流行率以及阿片类药物的高风险,
过量释放后,刑事司法(CJ)系统提供了一个有针对性的机会,让个人参与
治疗开始。尽管MOUD有强大的证据基础,但很少有惩教机构提供这些生活-
节省药物。立法和法院裁决中不断变化的政策格局将导致更多的设施
提供MOUD治疗。然而,交付障碍仍然存在。一种新的可注射缓释形式的
丁丙诺啡(XR-B)可以帮助克服这些障碍,尽管没有发表的文献,
在CJ环境中的有效性或实施。本K23提出了一项随机对照试验(RCT),
证明XR-B的初步有效性、可接受性和可行性,并使用伴随过程
评估,与框架经常使用的实施科学,以调查如何这种新的治疗
在CJ环境中可以使用这种方式,以防止阿片类药物过量,
社区
本K23提案的具体目标包括:(目标1)比较XR-B启动与常规治疗
舌下丁丙诺啡在治疗参与,重新监禁,
过量、丁丙诺啡依从性和非法阿片类药物使用。(Aim 2)使用RE-
AIM评价框架和iPARIHS执行科学框架,以评估
XR-B启动并确定CJ环境中MOUD治疗的促进因素和障碍。
为了实现这些目标并走向研究独立,伯克博士将接受培训
临床试验研究经验,包括支持定性方法和实施
科学,并建立一个职业生涯,在边缘化人群中进行高影响力和道德研究。
英文摘要
PROJECT SUMMARY
This K23 application proposes novel research in opioid use disorder (OUD) treatment in a correctional
healthcare setting and a robust training plan to support the successful transition of the Dr. Justin Berk, MD
MPH MBA (PI) to independent clinician-scientist. His background in public health, health management, and
clinical medicine creates a strong foundation for further development as an expert scientist. He has assembled
a highly accomplished and diverse team of nationally recognized mentors and advisors with complementary
expertise in clinical trials and other research among vulnerable populations including qualitative methodologies
and implementation science. The proposed research work will provide hands-on experience instrumental to Dr.
Berk’s career progression as a clinical trialist preliminary data for a future multi-site R01 application. The
Rhode Island Department of Corrections (RIDOC) is an ideal setting for this type of pilot study.
Medications for opioid use disorder (MOUD) are an effective treatment in the community and among
incarcerated individuals. Given the high prevalence OUD in jails and prisons and the high risk of opioid
overdose upon release, the criminal justice (CJ) system offers a targeted opportunity to engage individuals in
treatment initiation. Despite the strong evidence-base for MOUD, few correctional facilities offer these life-
saving medications. A shifting policy landscape in legislation and court rulings will lead to more facilities
offering MOUD treatment. Delivery barriers, however, still exist. A new injectable extended-release form of
buprenorphine (XR-B) can help overcome these barriers, though there is no published literature on its
effectiveness or implementation in a CJ setting. This K23 proposes a randomized controlled trial (RCT) to
demonstrate preliminary effectiveness, acceptability, and feasibility of XR-B and uses a concomitant process
evaluation, with frameworks frequently used in implementation science, to investigate how this novel treatment
modality may be used in a CJ setting to prevent opioid overdose in the high-risk time of re-entry to the
community.
The specific aims of this K23 proposal include: (Aim 1) Compare XR-B initiation to treatment-as-usual
sublingual buprenorphine among incarcerated individuals on treatment engagement, re-incarceration,
overdose, buprenorphine adherence, and illicit opioid use. (Aim 2) Conduct a process evaluation using the RE-
AIM evaluative framework and iPARIHS implementation science framework to assess the implementation of
XR-B initiation and identify facilitators to and barriers of MOUD treatment in a CJ setting.
In order to achieve these aims and move towards research independence, Dr. Berk will receive training
and experience in clinical trial research, including supporting qualitative methodologies and implementation
science, and build a career to conduct high-impact and ethical research in a marginalized population.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The Role of Medical Education Podcasts in Pediatrics.
医学教育播客在儿科中的作用。
DOI:
10.1542/peds.2023-062911
发表时间:
2023
期刊:
Pediatrics
影响因子:
8
作者:
[Parga-Belinkie,JoannaJ, Cosmini,Michael, Hill,David, Berk,Justin, Lockwood,Katie, Patrick,Michael, Novak,Chris, Tarchichi,TonyR]
通讯作者:
Tarchichi,TonyR
Commentary: Mobile health units: Paving the way for a new era of methadone treatment.
评论:移动医疗单位:为美沙酮治疗的新时代铺平道路。
DOI:
10.1016/j.josat.2023.209160
发表时间:
2023
期刊:
Journal of substance use and addiction treatment
影响因子:
--
作者:
[Berk,Justin]
通讯作者:
Berk,Justin
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
-
批准号:10426411
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2022
-
负责人:Justin Berk
-
依托单位:
海外基金